Xenetic Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Xenetic Biosciences

11/08/2023 14:31

* Xenetic Biosciences Inc  XBIO.OQ  reported a quarterly
adjusted
loss of 69 cents​​ per share for the quarter ended in June. The
lone analyst forecast for the quarter was for a loss of $1.13
per share.
    * Revenue rose 56.2% to $651.01 thousand from a year ago;
analysts
expected $440.00 thousand. 
    * Xenetic Biosciences Inc's reported EPS for the quarter was
a
loss of 69 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Xenetic Biosciences Inc shares had risen by 10.1% this
quarter and gained 26.6% so far this year.
    * The company reported a quarterly loss of $1.05 million.
    * Wall Street's median 12-month price target for Xenetic
Biosciences Inc is $40.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 11 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -1.13          -0.69          Beat
 Mar. 31 2023      -1.10          -0.60          Beat
 Dec. 31 2022      -0.90          -1.00          Missed
 Sep. 30 2022      -1.80          -0.60          Beat